Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.

about

Biomarkers of Cardiac Disease in Duchenne Muscular Dystrophy are Insufficient in the Absence of Clinical Cardiologic and Neurologic Assessment.

P2860

Q49788523-888FBCEA-8319-4E42-84ED-FA7F96C0433A

P2860

Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.

Item

http://www.wikidata.org/entity/Q38640186

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Interleukin 1 Receptor-Like 1 ...... n Duchenne Muscular Dystrophy.

@en

type

Item

label

Interleukin 1 Receptor-Like 1 ...... n Duchenne Muscular Dystrophy.

@en

prefLabel

Interleukin 1 Receptor-Like 1 ...... n Duchenne Muscular Dystrophy.

@en

P1476

Interleukin 1 Receptor-Like 1 ...... in Duchenne Muscular Dystrophy

@en

P2093

CINRG Investigators

http://www.w3.org/2001/XMLSchema#string

Haeri Seol

http://www.w3.org/2001/XMLSchema#string

Heather Gordish-Dressman

http://www.w3.org/2001/XMLSchema#string

Julia Anderson

http://www.w3.org/2001/XMLSchema#string

Yetrib Hathout

http://www.w3.org/2001/XMLSchema#string

P2860

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies

Biomarkers in heart failure

Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies.

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

National Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain.

Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used.

The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.

P2888

s00246-017-1703-9

P304

1606-1612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00246-017-1703-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher F Spurney

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091237853

http://www.w3.org/2001/XMLSchema#string

P698

28821969

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

6317901

http://www.w3.org/2001/XMLSchema#string

Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.

about

P2860

P2860

Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932